Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease

Background: In patients with chronic kidney disease (CKD), there is an overproduction and accumulation of advanced glycation end-products (AGEs). Since AGEs may have detrimental effects on muscular trophism and performance, we evaluated whether they may contribute to the onset of sarcopenia in CKD p...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Paolo Molinari, Lara Caldiroli, Elena Dozio, Roberta Rigolini, Paola Giubbilini, Massimiliano M. Corsi Romanelli, Giuseppe Castellano, Simone Vettoretti
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Subjects:	advanced glycation end-products (AGEs) chronic kidney disease (CKD) sarcopenia soluble receptor for AGE (sRAGE) cleaved RAGE (cRAGE) endogenous secretory RAGE (esRAGE)
Online Access:	https://www.mdpi.com/2227-9059/10/7/1489

Similar Items

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
by: Lara Caldiroli, et al.
Published: (2022-06-01)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2021-12-01)

Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study
by: Paolo Molinari, et al.
Published: (2023-01-01)

esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation
by: Jessica Swanner, et al.
Published: (2023-03-01)

The cardiovascular complications of diabetes: a striking link through protein glycation
by: Ahmad Mousa Numan, et al.
Published: (2020-12-01)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases
by: Fabrizio Guarneri, et al.
Published: (2021-01-01)

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
by: Elena Dozio, et al.
Published: (2020-12-01)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
by: Diana Elizabeth González-Guerrero, et al.
Published: (2023-04-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Level and Its Prognostic Significance in Children with Acute Lymphoblastic Leukemia
by: Busra Ozkan, et al.
Published: (2024-01-01)

Construction and evaluation of a diagnostic model for metabolic dysfunction-associated steatotic liver disease based on advanced glycation end products and their receptors
by: Xiao Cao, et al.
Published: (2025-03-01)

Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years
by: Julie Magnier, et al.
Published: (2022-06-01)

RAGE Inhibitors in Neurodegenerative Diseases
by: V. Prakash Reddy, et al.
Published: (2023-04-01)

Concentrations of N<sup>6</sup>-Carboxymethyllysine (CML), N<sup>6</sup>-Carboxyethyllysine (CEL), and Soluble Receptor for Advanced Glycation End-Products (sRAGE) Are Increased in Psoriatic Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2022-12-01)

sRAGE as a Prognostic Biomarker in ARDS: Insights from a Clinical Cohort Study
by: Ana Andrijevic, et al.
Published: (2025-01-01)

No Glycation Required: Interference of Casein in AGE Receptor Binding Tests
by: Hannah E. Zenker, et al.
Published: (2021-08-01)

A Potential Role for the Receptor for Advanced Glycation End-Products (RAGE) in the Development of Secondhand Smoke-Induced Chronic Sinusitis
by: Hannah Robin, et al.
Published: (2024-01-01)

High-mobility group box 1 protein, receptor for advanced glycation end products and nucleosomes increases after marathon
by: Julia Schoenfeld, et al.
Published: (2023-02-01)

Study of the mechanism by gentiopicroside protects against skin fibroblast glycation damage via the RAGE pathway
by: Chunyu Chen, et al.
Published: (2024-02-01)

Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study
by: Nahla A Tayyib, et al.
Published: (2023-12-01)

A Decolonial Reading of EFF as (Mis)Guided Black Rage
by: Mbuyisi Mgibisa
Published: (2025-08-01)

Soluble receptor for advanced glycation end product (sRAGE) levels in adolescents with obesity, insulin resistance and metabolic syndrome: A case-control study and the review of the literature
by: Pembe Soylu Ustkoyuncu, et al.
Published: (2025-09-01)

Significant Interrelations among Serum Annexin A1, Soluble Receptor for Advanced Glycation End Products (sRAGE) and rs2070600 in Chronic Obstructive Pulmonary Disease
by: Amira A. Kamel, et al.
Published: (2022-11-01)

Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease
by: Marcin Woźniak, et al.
Published: (2021-03-01)

Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
by: Carlos Machahua, et al.
Published: (2018-11-01)

Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy
by: Sára Csiha, et al.
Published: (2025-02-01)

Book review: Tucker, Terrence T. (2018). Furiously Funny: Comic Rage from Ralph Ellison to Chris Rock. Gainesville: University Press of Florida.
by: Tereza Walsbergerová
Published: (2021-04-01)

Diabetic Glycation of Human Serum Albumin Affects Its Immunogenicity
by: Cresci-Anne C. C. Croes, et al.
Published: (2024-11-01)

HMGB1/RAGE axis in tumor development: unraveling its significance
by: Anqi Fan, et al.
Published: (2024-03-01)

Contribution of Glycation and Oxidative Stress to Thyroid Gland Pathology—A Pilot Study
by: Aleksandra Kuzan, et al.
Published: (2021-04-01)

Un foyer de rage cameline en Mauritanie
by: Sidya Ould Bah, et al.
Published: (1981-03-01)

Etude de la spécificité d'anticorps monoclonaux obtenus avec la souche de virus de rage Pasteur PV
by: Geneviève Libeau, et al.
Published: (1984-04-01)

Rage furieuse de l’enfant transmise par un chat errant : à propos d’un cas et revue de la littérature
by: Savadogo M, et al.
Published: (2018-04-01)

Decreased Expression of Pulmonary Homeobox NKX2.1 and Surfactant Protein C in Developing Lungs That Over-Express Receptors for Advanced Glycation End-Products (RAGE)
by: Derek M. Clarke, et al.
Published: (2023-07-01)

Screening of Potential Compounds in Tomato (<i>Solanum lycopersicum</i>) as Candidates for Anti Diabetes Mellitus Complications
by: Sekararum Narwasthu, et al.
Published: (2024-08-01)

Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review
by: Mengzhou Zhou, et al.
Published: (2024-08-01)

Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development
by: Chenping Du, et al.
Published: (2022-11-01)

Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses
by: Kaylen Cross, et al.
Published: (2024-12-01)

Antenatal Secondhand Smoke (SHS) Exposure and the Receptor for Advanced Glycation End-Products (RAGE)
by: Katrina L. Curtis, et al.
Published: (2024-01-01)

Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases
by: Vanesa Cepas, et al.
Published: (2020-02-01)